Bioavailability Study of Hemp Phenolics

Status Active, not recruiting

Clinical Trial Summary

The aim is to determine the bioavailability of the polyphenol fraction form a commercially available hemp hull fiber at two different amounts in generally healthy adults. Additional objectives include determining specific metabolites produced over a 24 to 48-hour period following the hemp fiber consumption. Subjects will consume a study pudding that will be used to deliver a low and a high dose fiber product. Blood samples will be collected to measure background levels of metabolites. At day 0 participants will consume a low dose study product and day 6 the high dose study product and provide blood samples over an 8 hr period after study product consumption, to be followed by a 24 hr blood sample and 48 hr blood sample. Additionally following the low / high dose study product 24 and 48 h urine samples will be collected.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06098001
Study type	Interventional
Source	Brightseed
Contact
Status	Active, not recruiting
Phase	N/A
Start date	September 15, 2023
Completion date	December 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT06043739` - Relative Bioavailability and Effect of Food Study With an Oral Mini-tablet Formulation of Filgotinib in Healthy Subjects	Phase 1
Completed	`NCT02557139` - Bioavailability of Belumosudil (KD025) in Healthy Male Subjects	Phase 1
Completed	`NCT02010944` - A Study to Compare How Much Solifenacin Succinate and Mirabegron Reach the Blood When Administered Together as Fixed-dose Combination Tablets and With Single Individual Tablets of the Same Medications at Three Dose Levels	Phase 1
Completed	`NCT01208155` - Study in Healthy Males to Assess Bioavailability of 4 Different Fostamatinib Tablets	Phase 1
Not yet recruiting	`NCT01136551` - Comparative Bioavailability Study of an Immediate Release and Controlled Release Oral Formulations of Huperzine A	N/A
Completed	`NCT04097808` - Impact of the Source and Food Matrices on the Bioavailability of Peptan® (Collagen Peptides) in Healthy Subjects	N/A
Completed	`NCT01912144` - Absorption of Phenolic Acids From Coffee in Humans	N/A
Completed	`NCT03915626` - Effect of Heat on Rivastigmine TDS Products	Early Phase 1
Completed	`NCT01464450` - Pharmacokinetics Study of Oral Rivaroxaban in Healthy Participants	Phase 1
Completed	`NCT01448772` - Comparative Bioavailability of Dronabinol Oral Solution Versus Branded Capsule 5 mg Under Fasting Conditions	Phase 1
Completed	`NCT01181973` - Safety, Tolerability and Relative Bioavailability of Pegvisomant in Healthy Subjects	Phase 1
Completed	`NCT00858767` - Arabic Gum-Absorption Study	N/A
Completed	`NCT04113564` - Absolute Oral Bioavailability of Remimazolam	Phase 1
Completed	`NCT04645394` - Bioavailability of Anthocyanins From Aronia Extract in Healthy Men - a Pilot Study	N/A
Completed	`NCT03485885` - Bioavailability of Maqui Berry Extract (MBE) in Healthy Subjects
Completed	`NCT05840848` - Effect of Iron and Zinc Supplementation on B-carotene Bioavailability in Healthy Males	N/A
Completed	`NCT02986529` - A Study to Assess the Bioavailability of Oral Sodium Oligo-mannurarate (GV-971) in Healthy Chinese Male Subjects	Phase 1
Completed	`NCT01789359` - Urinary Excretion of Anthocyanins During Long Term Blueberry Feeding	N/A
Completed	`NCT01638143` - Bio-equivalence Study	N/A
Completed	`NCT00755872` - Assess the Influence of a High-fat Meal on the Relative Bioavailability Of Two Formulations of Risedronate	Phase 1